Cargando…
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis
OBJECTIVE: Experimental evidence suggests that metabolic syndrome (MetS) is associated with changes in cardiac metabolism. Whether this association occurs in humans is unknown. RESEARCH DESIGN AND METHODS: 821 asymptomatic individuals from the Progression of Early Subclinical Atherosclerosis (PESA)...
Autores principales: | Devesa, Ana, Fuster, Valentin, Vazirani, Ravi, García-Lunar, Inés, Oliva, Belén, España, Samuel, Moreno-Arciniegas, Andrea, Sanz, Javier, Perez-Herreras, Cristina, Bueno, Héctor, Lara-Pezzi, Enrique, García-Alvarez, Ana, de Vega, Vicente Martínez, Fernández-Friera, Leticia, Trivieri, Maria G., Fernández-Ortiz, Antonio, Rossello, Xavier, Sanchez-Gonzalez, Javier, Ibanez, Borja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632182/ https://www.ncbi.nlm.nih.gov/pubmed/37713581 http://dx.doi.org/10.2337/dc23-0871 |
Ejemplares similares
-
Association Between Body Size Phenotypes and Subclinical Atherosclerosis
por: Rossello, Xavier, et al.
Publicado: (2020) -
Bone marrow activation in response to metabolic syndrome and early atherosclerosis
por: Devesa, Ana, et al.
Publicado: (2022) -
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study
por: Tristão-Pereira, Catarina, et al.
Publicado: (2023) -
Triglycerides and Residual Atherosclerotic Risk
por: Raposeiras-Roubin, Sergio, et al.
Publicado: (2021) -
Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study
por: Sánchez-Cabo, Fátima, et al.
Publicado: (2023)